Thebaine Urine Testing

N/ARecruitingNCT07192887

Children's Hospital Medical Center, Cincinnati20 enrolled

Overview

To develop and validate a urine drug screen to detect thebaine.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Urine Specimen Collection

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female * Ages 18-65 * Healthy Exclusion Criteria: * Allergy to poppy seeds, or any of the related food stuffs used in the study * Celiac disease or gluten sensitivity * Ongoing or opioid use in the past 6 months * History of renal or hepatic disease or dysfunction * Inability or unwillingness to give repeated urine specimens * Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study * Non-English speakers (due to study materials being in English) * BMI greater than 30 * Antibiotic use in the previous 2 months * Recent ingestion of poppy seeds from the previous 7 days

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

RECRUITING

Outcomes

Primary Outcomes

Validate thebaine urine screen

Validate a liquid chromatography-tandem mass spectrometry method to detect thebaine in urine

Time frame: Enrollment to 48 hours after enrollment

Central Contacts

Charlotte Walter, MD

CONTACT

513-636-4408 charlotte.walter@cchmc.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.